Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.4
Stockholders’ Equity (Details Narrative) - USD ($)
$ in Thousands
 2 Months Ended 12 Months Ended
Mar. 28, 2022
Mar. 08, 2023
Dec. 31, 2022
Dec. 31, 2021
Nov. 30, 2022
Subsidiary or Equity Method Investee [Line Items]          
Common stock, shares outstanding     40,518,792 34,917,907  
Proceeds from Issuance of Common Stock     $ 1,807  
Securities sold under agreements to repurchase $ 1,000        
Common stock, sold value     $ 41 $ 35  
Controlled Equity Offering Agreement [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Common stock, sold value         $ 6,500
Shares sold through at-the-market equity facility, shares     0    
Controlled Equity Offering Agreement [Member] | Subsequent Event [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Shares sold through at-the-market equity facility, shares   230,068      
Sold shares through at-the-market equity facility, value   $ 300      
Cantor Fitzgerald [Member] | Commited Equity Facility [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Stock purchase of shares $ 50,000        
Issuance of common stock - IPO, net of fees, shares 680,263        
Pavmed Inc [Member]          
Subsidiary or Equity Method Investee [Line Items]          
Majority-interest equity ownership shares     31,302,420